- 22.9% Q4 Revenue Decline despite year-end performance aligning with revised expectations.
- 37.2% Full-Year Revenue Drop attributed to cost-cutting and supply chain adjustments.
- $850M–$900M 2026 Revenue Guidance reflects demand normalization and production ramp-up plans.
- 13% Gross Margin Target anticipated as 2025 cost reductions stabilize operations.
- 200,000+ sq ft U.S. Facility Expansion aims to boost manufacturing capacity and efficiency.
Operational Adjustments and Cost-Cutting Measures
The company implemented cost-cutting measures, including reducing production, rightsizing its cost structure, and strengthening its supply chain, in response to the challenging industry environment. According to Deborah L. Whitmire, these measures have positioned the company for a strong recovery. "We have greater visibility into retail demand, and our distributor inventory levels are now back to historical norms," she noted.
Market Outlook and Growth Drivers
William G. Miller discussed the company's market outlook for 2026, stating that the domestic market is now normalized, with steadier retail demand and improved sales order entry. The company expects production levels to rise methodically throughout Q1 and Q2 to match this demand recovery. Miller also highlighted the company's export business, which remains a major driver of growth, with a robust pipeline of global military RFQs providing a strong multi-year growth tailwind.
Strategic Investments and Acquisitions
The company is investing in its European operations, including the acquisition of OMARS, which will provide new sales, a stronger brand presence, and a strategic manufacturing hub in the European market. Miller noted that OMARS will be accretive in year one and provide significant synergies in the long term, including cross-selling and cross-manufacturing opportunities.
Valuation and Growth Prospects
With the company's revenue expected to grow by 7.6% in 2026, the current valuation multiples appear reasonable. The stock trades at a P/E Ratio of 22.8, P/B Ratio of 1.25, and P/S Ratio of 0.67. The company's return on equity (ROE) is 5.52%, and its return on invested capital (ROIC) is 5.04%. The dividend yield is 1.74%, providing a relatively stable source of return for investors.